AGL 2043   Click here for help

GtoPdb Ligand ID: 5918

Synonyms: AGL-2043 | AGL2043 | HMS3229A05
Compound class: Synthetic organic
Comment: This is compound 13 in [3].
AGL 2043 is a potent, reversible, ATP-competitive inhibitor of type III receptor tyrosine kinases (PDGFR, CSFR, Kit, FLT3 receptor family).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 1
Topological polar surface area 71.84
Molecular weight 280.08
XLogP 1.89
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1c(C)nc2c1cc1ncc(nc1c2)c1cccs1
Isomeric SMILES Cn1c(C)nc2c1cc1ncc(nc1c2)c1cccs1
InChI InChI=1S/C15H12N4S/c1-9-17-12-6-11-10(7-14(12)19(9)2)16-8-13(18-11)15-4-3-5-20-15/h3-8H,1-2H3
InChI Key ZGDACLBJJXLKJY-UHFFFAOYSA-N
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
platelet derived growth factor receptor beta Primary target of this compound Hs Inhibitor Inhibition 7.1 pIC50 - 3
pIC50 7.1 (IC50 9x10-8 M) [3]
Description: Using purified human PDGFRβ